Akymed Overview

  • Founded
  • 2006
Founded
  • Status
  • Private
  • Employees
  • 5
Employees
  • Latest Deal Type
  • Accelerator/​Inc
  • Investors
  • 1

Akymed General Information

Description

Developer of a male fertility analysis software designed to analyze sperms. The company's male fertility analysis software uses automated image recognition technology to deliver reproducible analysis within 4 seconds, enabling users to analyze sperms at home and get laboratory quality results.

Contact Information

Website
www.akymed.com
Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Other Healthcare Technology Systems
Primary Office
  • EPFL Innovation Park
  • Building A
  • 1015 Lausanne
  • Switzerland
+41 058 000 00 00
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Akymed Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
1. Accelerator/Incubator Completed Startup
To view Akymed’s complete valuation and funding history, request access »

Akymed Patents

Akymed Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-2440923-A1 Method and apparatus for evaluation of toxicity Withdrawn 08-Jun-2009 00000000000
US-20120135451-A1 Method and apparatus for evaluation of toxicity Abandoned 08-Jun-2009 00000000000
US-8009888-B2 Mobile device for particle analysis by image correlation Active 17-Jul-2006 000000000000
US-20090238423-A1 Mobile device for particle analysis by image correlation Granted 17-Jul-2006 000000000000 0
JP-2009544024-A Mobile particle analyzer with image correlation Pending 17-Jul-2006 G01N35/00871

Akymed Executive Team (5)

Name Title Board Seat Contact Info
Erik Nordquist Co-Founder, Chief Executive Officer and Chairman
Rudolf Rigler Ph.D Co-Founder
You’re viewing 2 of 5 executive team members. Get the full list »

Akymed Board Members (1)

Name Representing Role Since
Erik Nordquist Akymed Co-Founder, Chief Executive Officer and Chairman 000 0000
To view Akymed’s complete board members history, request access »

Akymed Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Akymed Investors (1)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
EPFL Innovation Park Accelerator/Incubator 000 0000 000000 0
To view Akymed’s complete investors history, request access »